Effect of intravenous immunoglobulin (IVIG) on CD4+ lymphocyte decline in HIV-infected children in a clinical trial of IVIG infection prophylaxis. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.

Mofenson, L M; Bethel, J; Moye, J; Flyer, P; Nugent, R

Mofenson, L M; Bethel, J; Moye, J; Flyer, P; Nugent, R.

Affiliation

Mofenson LM; Adolescent and Maternal AIDS Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892.

J Acquir Immune Defic Syndr (1988) ; 6(10): 1103-13, 1993 Oct.

Article in En | MEDLINE | ID: mdl-8105072

Subject(s)

CD4-Positive T-Lymphocytes/immunology; HIV Infections/prevention & control; Immunoglobulins, Intravenous/therapeutic use; Age Factors; Analysis of Variance; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections/drug therapy; Humans; Infant; Leukocyte Count; Linear Models; Longitudinal Studies; Male; Regression Analysis; Time Factors; Treatment Outcome; Zidovudine/therapeutic use

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: CD4-Positive T-Lymphocytes / HIV Infections / Immunoglobulins, Intravenous Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: J Acquir Immune Defic Syndr (1988) Journal subject: DOENCAS SEXUALMENTE TRANSMISSIVEIS / SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 1993 Type: Article

Search on Google

XML

PubMed Links